MDL-207

N/A

Report date: 2025/08/29 17:06:04

Base Information

Drug NameMDL-207
Drug Alias NameMDL-207
ClassificationCell and gene therapy > Gene therapy > Gene editing > CRISPR
Mechanisms of ActionSodium channel protein type I alpha subunit stimulants
TargetsSodium channel protein type I alpha subunit
Therapy Area/IndicationsEpilepsies, Myoclonic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesModalis Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesModalis Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsEpilepsies, Myoclonic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A